C07C39/245

Process for preparing 3-chloro-2-vinylphenylsulfonates

The present invention relates to a new process for preparing 3-chloro-2-vinylphenylsulfonate derivatives.

Process for preparing 3-chloro-2-vinylphenylsulfonates

The present invention relates to a new process for preparing 3-chloro-2-vinylphenylsulfonate derivatives.

Synthesis of fluorinated radiopharmaceuticals via electrochemical fluorination

Provided herein are methods and compositions for the electrochemical selective radiofluorination of aromatic molecules. The resulting fluorine-18 labeled compounds are ideal radionuclides for use in Positron Emission Tomography (PET); they are also difficult to radiolabel efficiently and with high specific activity using existing approaches. For example, radiopharmaceuticals such as [F18]L-DOPA, which is indispensable in PET brain disease imaging, may be made electrochemically with high radiochemical yield and high specific activity using 18F-. The invention process described herein opens new possibilities and provides wider access to PET tracers such as 18F-L-Dopa, since 18F- is much more widely available than the 18F.sub.2, currently used for synthesis of electron rich substrates.

2-POSITION MODIFICATION FOR SYNTHESIS OF RESORCINOL SCAFFOLDING
20200079715 · 2020-03-12 ·

A resorcinol with modifications at the 2-position is provided. The reactant resorcinol may have a variety of functional groups at each of the 1, 3, and 5 position such as a hydroxide, a lower alkyl group, a phenyl, a substituted phenyl, a lower alkenyl, or a lower alkynyl sp.sup.2 carbon group (e.g., substituted phenyl, vinyl), sp (e.g., alkyne), hydrogen. The resorcinol is modified at the 2-position with a nucleophile or an electrophile. The resulting resorcinol may serve as a stable intermediate for the synthesis of cannabinoid or cannabinoid derivatives.

2-POSITION MODIFICATION FOR SYNTHESIS OF RESORCINOL SCAFFOLDING
20200079715 · 2020-03-12 ·

A resorcinol with modifications at the 2-position is provided. The reactant resorcinol may have a variety of functional groups at each of the 1, 3, and 5 position such as a hydroxide, a lower alkyl group, a phenyl, a substituted phenyl, a lower alkenyl, or a lower alkynyl sp.sup.2 carbon group (e.g., substituted phenyl, vinyl), sp (e.g., alkyne), hydrogen. The resorcinol is modified at the 2-position with a nucleophile or an electrophile. The resulting resorcinol may serve as a stable intermediate for the synthesis of cannabinoid or cannabinoid derivatives.

METHOD FOR PREPARING 3-SUBSTITUTED 2-VINYLPHENYL SULFONATES
20200071267 · 2020-03-05 ·

The present invention relates to a method for preparing 3-substituted 2-vinylphenyl sulfonates.

METHOD FOR PREPARING 3-SUBSTITUTED 2-VINYLPHENYL SULFONATES
20200071267 · 2020-03-05 ·

The present invention relates to a method for preparing 3-substituted 2-vinylphenyl sulfonates.

Aminated lignin-derived compounds and uses thereof

The present invention relates to novel lignin-derived compounds and compositions comprising the same and their use as redox flow battery electrolytes. The invention further provides a method for preparing said compounds and compositions as well as a redox flow battery comprising said compounds and compositions. Additionally, an assembly for carrying out the inventive method is provided.

SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT

The instant invention relates to seaweed extract compositions, processes for isolation, isolated active agents, and methods of treating disease, disorders and conditions in a subject, including, reactive oxygen species (ROS)-mediated diseases and diseases mediated through the activation of the Nrf2-ARE (antioxidant response element) pathway, including proliferative diseases and disorders, Alzheimer's disease, stroke, and certain diseases and disorders of aging and associated with aging and exposure, by use of the extracts, compounds, and compositions thereof.

SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT

The instant invention relates to seaweed extract compositions, processes for isolation, isolated active agents, and methods of treating disease, disorders and conditions in a subject, including, reactive oxygen species (ROS)-mediated diseases and diseases mediated through the activation of the Nrf2-ARE (antioxidant response element) pathway, including proliferative diseases and disorders, Alzheimer's disease, stroke, and certain diseases and disorders of aging and associated with aging and exposure, by use of the extracts, compounds, and compositions thereof.